|Bid||218.00 x 1100|
|Ask||224.10 x 800|
|Day's range||218.37 - 225.38|
|52-week range||173.45 - 371.16|
|Beta (5Y monthly)||1.13|
|PE ratio (TTM)||50.66|
|Earnings date||07 Feb 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||243.50|
Alnylam (ALNY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced Joydeep Goswami has been appointed Chief Financial Officer, effective immediately. Goswami previously served as Illumina's Chief Strategy and Corporate Development Officer and interim Chief Financial Officer. As CFO, Goswami will be responsible for the Company's financial planning and analysis, accounting, investor relations, internal audit, tax, and treasury functions. He will also con
Illumina (ILMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.